Our recognition
Latest stories
Featured
Hikma delivers strong 2023 performance and a positive outlook for 2024
Press Release, Financial Results
22 February 2024
- Hikma announces settlement agreement for Xyrem® (sodium oxybate) U.S. class action lawsuits Press Release, Corporate 08 May 2025 Hikma announces settlement agreement for Xyrem® (sodium oxybate) U.S. class action lawsuits
- S&P upgrades Hikma Pharmaceuticals PLC and its Senior Notes to ‘BBB’ on continued good business momentum; outlook stable Press Release, Corporate 08 May 2025 S&P upgrades Hikma Pharmaceuticals PLC and its Senior Notes to ‘BBB’ on continued good business momentum; outlook stable
- Hikma reiterates full year guidance following good start to the year Press Release, Corporate 24 April 2025 Hikma reiterates full year guidance following good start to the year
- Inspiring women of Hikma - Meet Nesrine Nouhi, General Manager of Hikma France Insight, Life at Hikma 17 April 2025 Inspiring women of Hikma - Meet Nesrine Nouhi, General Manager of Hikma France
Related content